We are live on ! Find out more
CCB

Cutter & Co Brokerage Portfolio holdings

AUM $423M
1-Year Est. Return 15.02%
This Fund
S&P 500
This Quarter Est. Return
+11.34%
1 Year Est. Return
+15.02%
3 Year Est. Return
+40.36%
5 Year Est. Return
+171.67%
10 Year Est. Return
+252.8%
AUM
$296M
AUM Growth
+$26.6M
Cap. Flow
+$3.96M
Cap. Flow %
1.34%
Top 10 Hldgs %
41.19%
Holding
240
New
14
Increased
65
Reduced
107
Closed
23

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$10.4M
2
CDRE icon
Cadre Holdings
CDRE
+$2.58M
3
WFC icon
Wells Fargo
WFC
+$635K
4
NFG icon
National Fuel Gas
NFG
+$544K
5
LIN icon
Linde
LIN
+$529K

Top Sells

Rank Stock Value
1
GMAB icon
Genmab
GMAB
+$3.77M
2
TDS icon
Telephone and Data Systems
TDS
+$1.94M
3
UGI icon
UGI
UGI
+$751K
4
IFF icon
International Flavors & Fragrances
IFF
+$736K
5
SR icon
Spire
SR
+$553K

Sector Composition

Rank Sector Weight
1 Financials 17.27%
2 Healthcare 15.41%
3 Energy 12.84%
4 Industrials 9.9%
5 Materials 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLTR icon
201
Palantir
PLTR
$295B
$118K 0.04%
18,441
+1,928
+12% +$14.6K
GNSS icon
202
Genasys
GNSS
$76.1M
$105K 0.04%
28,500
+1,000
+4% +$2.89K
VVR icon
203
Invesco Senior Income Trust
VVR
$457M
$83.7K 0.03%
21,857
+847
+4% +$3.22K
QVCGA
204
DELISTED
QVC Group Inc Series A
QVCGA
$74K 0.03%
908
-600
-40% -$61.2K
MNTX
205
DELISTED
Manitex International, Inc.
MNTX
$51.8K 0.02%
12,945
+576
+5% +$2.66K
TZOO icon
206
Travelzoo
TZOO
$74.3M
$51.2K 0.02%
11,500
-4,000
-26% -$20.1K
HRTX icon
207
Heron Therapeutics
HRTX
$93.9M
$31.6K 0.01%
12,655
-250
-2% -$805
OBSV
208
DELISTED
ObsEva SA Ordinary Shares
OBSV
$30.2K 0.01%
201,200
+2,800
+1% +$477
ENZ
209
DELISTED
Enzo Biochem, Inc.
ENZ
$25.3K 0.01%
17,706
-4,071
-19% -$7.93K
ZTEK
210
Zentek
ZTEK
$86.1M
$23.3K 0.01%
15,000
BNGO icon
211
Bionano Genomics
BNGO
$12.3M
$22.9K 0.01%
26
-69
-73% -$86.8K
PFIE
212
DELISTED
Profire Energy, Inc
PFIE
$19.5K 0.01%
18,350
DM
213
DELISTED
Desktop Metal, Inc.
DM
$16K 0.01%
1,179
-3,416
-74% -$71.2K
TPHS
214
DELISTED
Trinity Place Holdings Inc.com
TPHS
$14.1K ﹤0.01%
19,100
BLRX
215
BioLineRX
BLRX
$12.3M
$9.83K ﹤0.01%
417
-50
-11% -$1.49K
AXDX
216
DELISTED
Accelerate Diagnostics
AXDX
$9.64K ﹤0.01%
1,358
-20
-1% -$218
ASM
217
Avino Silver & Gold Mines
ASM
$934M
$6.8K ﹤0.01%
10,000
AGNC icon
218
AGNC Investment
AGNC
$12.4B
-16,170
Closed -$136K
CLF icon
219
Cleveland-Cliffs
CLF
$6.57B
-11,400
Closed -$154K
DNN icon
220
Denison Mines
DNN
$2.54B
-10,000
Closed -$12K
ELAN icon
221
Elanco Animal Health
ELAN
$13.2B
-15,182
Closed -$188K
GMAB icon
222
Genmab
GMAB
$17.7B
-117,306
Closed -$3.77M
MRAM icon
223
Everspin Technologies
MRAM
$341M
-10,000
Closed -$58K
MWA icon
224
Mueller Water Products
MWA
$3.95B
-21,300
Closed -$219K
NEOG icon
225
Neogen
NEOG
$2.63B
-10,828
Closed -$151K

Similar funds

Cutter & Co Brokerage's Q4 2022 Portfolio in Review

As of Q4 2022, Cutter & Co Brokerage held 240 positions worth $296M, up 9.9% from $269M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Cutter & Co Brokerage's Q4 2022 filing shows 14 new, 65 increased, 107 reduced and 23 closed positions. Its largest new stake was Wells Fargo: 14,355 shares worth $593K. The largest sale was Genmab, an estimated $3.77M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Energy.

  • Cutter & Co Brokerage's largest Q4 2022 buy was Wells Fargo: 14,355 shares worth $593K.
  • Cutter & Co Brokerage added most to Novo Nordisk in Q4 2022, an estimated $10.4M increase.
  • Cutter & Co Brokerage's biggest Q4 2022 reduction was International Flavors & Fragrances, cutting an estimated $736K.
  • Cutter & Co Brokerage fully exited Genmab in Q4 2022, selling an estimated $3.77M.
  • Cutter & Co Brokerage's ten largest holdings make up 41% of its $296M portfolio in Q4 2022.
  • Cutter & Co Brokerage opened 14 new positions and closed 23 in Q4 2022.
  • Cutter & Co Brokerage's portfolio value rose 9.9% quarter-over-quarter to $296M.

Based on Cutter & Co Brokerage's 13F filing for Q4 2022, filed 3 Feb 2023.